Efficacy of Postoperative Bladder Irrigation with Water for Injection in Reducing Recurrence Rates of Non Muscle Invasive Bladder Cancer

  • Grivas, Nikolaos (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Hastazeris, Konstantinos (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Kafarakis, Vasileios (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Tsimaris, Ioannis (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Aspiotis, Spiridon (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Stratis, Antonios (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus) ;
  • Stavropoulos, Nikolaos Efthimios (General Hospital, Department of Urology, Makriyianni Avenue, Ioannina, Perfecture of Epirus)
  • Published : 2014.03.01


The aim of the study was to investigate the results of bladder irrigation with Water for Injection (WFI) after transurethral resection of bladder tumours for comparison with those for adjuvant use of BCG. A total of 239 patients (158 with single tumours, group A, and 81 with multiple tumours, group B) received continuous intravesical postoperative irrigation with WFI. Some 128 patients received intravesical irrigation with WFI, followed by weekly instillations of BCG (group C). Recurrence-free rate (RFR) and recurrence-free intervals (RFI) were recorded. RFR for those patients who received only intravesical irrigation with WFI (groups A and B) was 75.8%, 66.2% and 63.2% at the 1st, 2nd and 3rd year of follow up, respectively. Corresponding rates for group C were 61.7%, 55.4% and 49%. Median RFI in group B were 18, 11, 15, 15 and 12 months for Ta, T1, grade 1, grade 2 and grade 3 tumours, respectively. In group C corresponding intervals were 20, 33, 8, 20 and 42 months. BCG improved RFR only in T1 (p=0.014) and grade 3 tumours (p=0.007). In conclusion, postoperative bladder irrigation with WFI could increase RFR during the first and second year of follow up.


  1. Chen J, Wang S, Xu H (2001). Curative effect of radical gastrectomy combined with peritoneal lavage with thermal hypoosmotic solution in treatment of gastric cancer. Zhonghua Yi Xue Za Zhi, 81, 730-2.
  2. Brocks CP, Buttner H, Bohle A (2005). Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. J Urol, 174, 1115-8.
  3. Brundell SM, Tucker K, Chatterton B, Hewett PJ (2002). The effect of lavage on intraabdominal cell burden. Surg Endosc, 16, 1064-7.
  4. Chang YM, Hsu KF, Yu JC, et al (2013). Distilled water peritoneal lavage in patients with rupture hepatocellular carcinoma. Hepatogastroenterology, 60, 140-3.
  5. Dalesio O, Schulman CC, Sylvester R, et al (1983). Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol, 129, 730-3.
  6. Fechner G, Pocha K, Schmidt D, Muller SC (2006). Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin. Int J Clin Pract, 60, 1178-80.
  7. Gkritsios P, Hatzimouratidis K, Kazantzidis S, et al (2013). Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. Int Urol Nephrol, [Epub ahead of print].
  8. Hall RR (1997). Application of clinical trials to the care of patients with bladder cancer. Eur Urol, 31, 42-6.
  9. Heney NM, Nocks BN, Daly JJ, et al (1982). Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol, 54, 152-7.
  10. Whelan P, Griffiths G, Stower M, et al (2001). Preliminary results of an MRC randomised controlled trial of post-operative irrigation of superficial bladder cancer. Br J Cancer, 85, 1.
  11. Babjuk M, Burger M, Zigeuner R, et al (2013). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol, 64, 639-53.
  12. Bohle A, Leyh H, Frei C, et al (2009). Single postoperative instillation of gemcitabine in patients with non-muscleinvasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur Urol, 56, 495-503.
  13. Bolkier M, Moskovitz B, Ginesin Y, Levin DR (1991). Effect of distilled water and bacillus Calmette-Guerin on exfoliated bladder tumor cells. Eur Urol, 19, 319-21.
  14. Tolley DA, Hargreave TB, Smith PH, et al (1988). Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). BMJ, 296, 1759-61.
  15. Weldon TE, Soloway MS (1975). Susceptibility of urothelium to neoplastic cellular implantation. Urology, 5, 824-7.
  16. Witjes JA (2009). Topic issue on new treatments in bladder cancer. World J Urol, 27, 285-7.
  17. Sakai Y, Fujii Y, Hyochi N, et al (2006). A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection. Hinyokika Kiyo, 52, 173-5.
  18. Torti FM, Lum BL (1987).Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy. Cancer, 59, 613-6.<613::AID-CNCR2820591307>3.0.CO;2-3
  19. Page BH, Levison VB, Curwen MP (1978). The site of recurrence of non-infiltrating bladder tumours. Br J Urol, 50, 237-42.
  20. Price J (1905). Surgical intervention in cases of generalized peritonitis. Proc Phila County Med Soc, 26, 192-5.
  21. Selman SH, Keck RW (2011). A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model. J Urol, 186, 702-6.
  22. Shapiro Amos, Ofer N. Gofrit (2012). Prevention of Bladder Tumor Recurrence, Evolving Trends in Urology, Dr. Sashi Kommu (Ed.), ISBN: 978-953-51-0811-5, InTech,
  23. Soloway MS, Masters S (1980). Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer, 46, 1158-63.<1158::AID-CNCR2820460514>3.0.CO;2-E
  24. Soloway MS, Bruck DS, Kim SS (2003). Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol, 170, 438-41.
  25. Solsona E, Iborra I, Ricos JV, et al (1999). Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup. J Urol, 161, 1120-3.
  26. Sylvester RJ, Oosterlinck W, van der Meijden AP (2004). A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol, 171, 2186-90.
  27. McDonald DF, Thorson T (1956). Clinical implications of transplantability of induced bladder tumours to intact transitional epithelium in dogs. J Urol, 75, 690-4.
  28. Huguet EL, Keeling NJ (2004). Distilled water peritoneal lavage after colorectal cancer surgery. Dis Colon Rectum, 47, 2114-9.
  29. Hyacinthe LM, Jarrett TW, Gordon CS, Vaughan ED, Whalen GF (1995). Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin related peptide (GRGDS). Ann Surg Oncol, 2, 450-6.
  30. Lin CH, Hsieh HF, Yu JC, et al (2006). Peritoneal lavage with distilled water during liver resection in patients with spontaneously ruptured hepatocellular carcinomas. J Surg Oncol, 94, 255-6.
  31. Moskovitz B, Levin DR (1987). Intravesical irrigation with distilled water during and immediately after transurethral resection and later for superficial bladder cancer. Eur Urol, 13, 7-9.
  32. Nargund VH, Tanabalan CK, Kabir MN (2012). Management of non-muscle-invasive (superficial) bladder cancer. Semin Oncol, 39, 559-72.
  33. Okamura K, Ono Y, Kinukawa T, et al (2002). Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyldoxorubicin for a single superficial bladder carcinoma. Cancer, 94, 2363-8.
  34. Onishi T, Sasaki T, Hoshina A, Yabana T (2011). Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor. Anticancer Res, 31, 1471-4.
  35. Oosterlinck W, Kurth KH, Schroder F, et al (1993). A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol, 149, 749-52.

Cited by

  1. Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer vol.16, pp.8, 2015,